These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 39151980)

  • 1. Cost-effectiveness and health impact of screening and treatment of Mycobacterium tuberculosis infection among formerly incarcerated individuals in Brazil: a Markov modelling study.
    van Lieshout Titan A; Klaassen F; Pelissari DM; de Barros Silva JN; Alves K; Alves LC; Sanchez M; Bartholomay P; Johansen FDC; Croda J; Andrews JR; Castro MC; Cohen T; Vuik C; Menzies NA
    Lancet Glob Health; 2024 Sep; 12(9):e1446-e1455. PubMed ID: 39151980
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ceftazidime with avibactam for treating severe aerobic Gram-negative bacterial infections: technology evaluation to inform a novel subscription-style payment model.
    Harnan S; Kearns B; Scope A; Schmitt L; Jankovic D; Hamilton J; Srivastava T; Hill H; Ku CC; Ren S; Rothery C; Bojke L; Sculpher M; Woods B
    Health Technol Assess; 2024 Oct; 28(73):1-230. PubMed ID: 39487661
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Falls prevention interventions for community-dwelling older adults: systematic review and meta-analysis of benefits, harms, and patient values and preferences.
    Pillay J; Gaudet LA; Saba S; Vandermeer B; Ashiq AR; Wingert A; Hartling L
    Syst Rev; 2024 Nov; 13(1):289. PubMed ID: 39593159
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genedrive kit for detecting single nucleotide polymorphism m.1555A>G in neonates and their mothers: a systematic review and cost-effectiveness analysis.
    Shabaninejad H; Kenny RP; Robinson T; Stoniute A; O'Keefe H; Still M; Thornton C; Pearson F; Beyer F; Meader N
    Health Technol Assess; 2024 Oct; 28(75):1-75. PubMed ID: 39487741
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessing long-term effectiveness and cost-effectiveness of statin therapy in the UK: a modelling study using individual participant data sets.
    Mihaylova B; Wu R; Zhou J; Williams C; Schlackow I; Emberson J; Reith C; Keech A; Robson J; Parnell R; Armitage J; Gray A; Simes J; Baigent C
    Health Technol Assess; 2024 Dec; 28(79):1-134. PubMed ID: 39644281
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of Two Modern Survival Prediction Tools, SORG-MLA and METSSS, in Patients With Symptomatic Long-bone Metastases Who Underwent Local Treatment With Surgery Followed by Radiotherapy and With Radiotherapy Alone.
    Lee CC; Chen CW; Yen HK; Lin YP; Lai CY; Wang JL; Groot OQ; Janssen SJ; Schwab JH; Hsu FM; Lin WH
    Clin Orthop Relat Res; 2024 Dec; 482(12):2193-2208. PubMed ID: 39051924
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A multicomponent psychosocial intervention to reduce substance use by adolescents involved in the criminal justice system: the RISKIT-CJS RCT.
    Coulton S; Nizalova O; Pellatt-Higgins T; Stevens A; Hendrie N; Marchand C; Vass R; Deluca P; Drummond C; Ferguson J; Waller G; Newbury-Birch D
    Public Health Res (Southampt); 2023 Mar; 11(3):1-77. PubMed ID: 37254608
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Collagenase injection versus limited fasciectomy surgery to treat Dupuytren's contracture in adult patients in the UK: DISC, a non-inferiority RCT and economic evaluation.
    Dias J; Tharmanathan P; Arundel C; Welch C; Wu Q; Leighton P; Armaou M; Corbacho B; Johnson N; James S; Cooke J; Bainbridge C; Craigen M; Warwick D; Brady S; Flett L; Jones J; Knowlson C; Watson M; Keding A; Hewitt C; Torgerson D
    Health Technol Assess; 2024 Dec; 28(78):1-262. PubMed ID: 39644138
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lamotrigine versus levetiracetam or zonisamide for focal epilepsy and valproate versus levetiracetam for generalised and unclassified epilepsy: two SANAD II non-inferiority RCTs.
    Marson AG; Burnside G; Appleton R; Smith D; Leach JP; Sills G; Tudur-Smith C; Plumpton CO; Hughes DA; Williamson PR; Baker G; Balabanova S; Taylor C; Brown R; Hindley D; Howell S; Maguire M; Mohanraj R; Smith PE
    Health Technol Assess; 2021 Dec; 25(75):1-134. PubMed ID: 34931602
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of cognitive behaviour therapy versus activity management, both delivered remotely, to treat paediatric chronic fatigue syndrome/myalgic encephalomyelitis: the UK FITNET-NHS RCT.
    Crawley E; Anderson E; Cochrane M; Shirkey BA; Parslow R; Hollingworth W; Mills N; Gaunt D; Treneman-Evans G; Rai M; Macleod J; Kessler D; Pitts K; Cooper S; Loades M; Annaw A; Stallard P; Knoop H; Van de Putte E; Nijhof S; Bleijenberg G; Metcalfe C
    Health Technol Assess; 2024 Oct; 28(70):1-134. PubMed ID: 39485730
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost-effectiveness of easy-access, risk-informed oral pre-exposure prophylaxis in HIV epidemics in sub-Saharan Africa: a modelling study.
    Phillips AN; Bershteyn A; Revill P; Bansi-Matharu L; Kripke K; Boily MC; Martin-Hughes R; Johnson LF; Mukandavire Z; Jamieson L; Meyer-Rath G; Hallett TB; Ten Brink D; Kelly SL; Nichols BE; Bendavid E; Mudimu E; Taramusi I; Smith J; Dalal S; Baggaley R; Crowley S; Terris-Prestholt F; Godfrey-Faussett P; Mukui I; Jahn A; Case KK; Havlir D; Petersen M; Kamya M; Koss CA; Balzer LB; Apollo T; Chidarikire T; Mellors JW; Parikh UM; Godfrey C; Cambiano V;
    Lancet HIV; 2022 May; 9(5):e353-e362. PubMed ID: 35489378
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost-effectiveness of group medical visits and microfinance interventions versus usual care to manage hypertension in Kenya: a secondary modelling analysis of data from the Bridging Income Generation with Group Integrated Care (BIGPIC) trial.
    Chay J; Su RJ; Kamano JH; Andama B; Bloomfield GS; Delong AK; Horowitz CR; Menya D; Mugo R; Orango V; Pastakia SD; Wanyonyi C; Vedanthan R; Finkelstein EA
    Lancet Glob Health; 2024 Aug; 12(8):e1331-e1342. PubMed ID: 39030063
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antioxidants for female subfertility.
    Showell MG; Mackenzie-Proctor R; Jordan V; Hart RJ
    Cochrane Database Syst Rev; 2017 Jul; 7(7):CD007807. PubMed ID: 28752910
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antioxidants for female subfertility.
    Showell MG; Mackenzie-Proctor R; Jordan V; Hart RJ
    Cochrane Database Syst Rev; 2020 Aug; 8(8):CD007807. PubMed ID: 32851663
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Strategies used for childhood chronic functional constipation: the SUCCESS evidence synthesis.
    Todhunter-Brown A; Booth L; Campbell P; Cheer B; Cowie J; Elders A; Hagen S; Jankulak K; Mason H; Millington C; Ogden M; Paterson C; Richardson D; Smith D; Sutcliffe J; Thomson K; Torrens C; McClurg D
    Health Technol Assess; 2024 Jan; 28(5):1-266. PubMed ID: 38343084
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diabetes as a risk factor for tuberculosis disease.
    Franco JV; Bongaerts B; Metzendorf MI; Risso A; Guo Y; Peña Silva L; Boeckmann M; Schlesinger S; Damen JA; Richter B; Baddeley A; Bastard M; Carlqvist A; Garcia-Casal MN; Hemmingsen B; Mavhunga F; Manne-Goehler J; Viney K
    Cochrane Database Syst Rev; 2024 Aug; 8(8):CD016013. PubMed ID: 39177079
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Undernutrition as a risk factor for tuberculosis disease.
    Franco JV; Bongaerts B; Metzendorf MI; Risso A; Guo Y; Peña Silva L; Boeckmann M; Schlesinger S; Damen JA; Richter B; Baddeley A; Bastard M; Carlqvist A; Garcia-Casal MN; Hemmingsen B; Mavhunga F; Manne-Goehler J; Viney K
    Cochrane Database Syst Rev; 2024 Jun; 6(6):CD015890. PubMed ID: 38860538
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Medications for chronic obstructive pulmonary disease: a historical non-interventional cohort study with validation against RCT results.
    Wing K; Williamson E; Carpenter JR; Wise L; Schneeweiss S; Smeeth L; Quint JK; Douglas I
    Health Technol Assess; 2021 Aug; 25(51):1-70. PubMed ID: 34463610
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Burden of disease scenarios by state in the USA, 2022-50: a forecasting analysis for the Global Burden of Disease Study 2021.
    GBD 2021 US Burden of Disease and Forecasting Collaborators
    Lancet; 2024 Dec; 404(10469):2341-2370. PubMed ID: 39645377
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Abrocitinib, tralokinumab and upadacitinib for treating moderate-to-severe atopic dermatitis.
    Edwards SJ; Karner C; Jhita T; Barton S; Marceniuk G; Yiu ZZN; Wittmann M
    Health Technol Assess; 2024 Jan; 28(4):1-113. PubMed ID: 38343072
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.